Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.07% to 7683.91, DAX (0.09%) to 15557.29, CAC40 (0.40%) to 7184.82, STOXX 600 (0.31%) to 453.26

Sep 22 ,2023

  • Synopsis:

    • European equity markets closed mostly lower with the UK +0.1% bucking the negative trend. Technology and Consumer Products outperformed. Construction and Utilities lagged.

    • Attention on mixed Eurozone flash PMI reading with manufacturing weaker, but services activity better than forecast. UK GfK consumer confidence hit a 20-month high in Sept at -21 versus prior -25, which was the strongest level since January 2022 just before Russia's invasion of Ukraine. Consumers becoming more confident about the economic outlook and their personal finances. Confidence in personal finances over the next year rose one point to -2. UK retail sales remained subdued in August, up 0.4% versus consensus 0.5% and prior 1.1% drop revised from 1.2% fall initially reported. Also, CBI Industrial Trends Orders in September at (18) in line with consensus (18) and prior (15).

    • Light on the corporate front. Zegona (ZEG.LN) confirmed talks to acquire Vodafone Group's (VOD.LN) Spanish business following press speculations regarding a potential deal.

    • Amidst subdued earnings releases, out of France, Robertet (RBT.FP), Solutions 30 (S30.FP), Alten (ATE.FP) posted latest numbers; Sanofi (SAN.FP) worsens Q3 prelim estimate of currency impact on business EPS -9.5% to -8.5% vs prior -7.5% to -6.5%. In Greece, Jumbo (BELA.GA) reported H1 earnings. In the UK, Ascential (ASCL.LN), Investec (INVP.LN), and Braemar (BMS.LN) are among other companies from the region to update investors with their latest numbers.

    • The week ahead sees SNB release its latest quarterly bulletin, ECB's Lagrade before EU Parliament committee, Germany Sep Ifo survey, Oct GfK consumer confidence, France Sep consumer confidence, Sep preliminary CPIs from across the region, SCHOTT Pharma (+SCHP.GR) makes its stock market debut, as well as earnings/updates from ASOS (ASC.LN), Ferguson (FERG.LN) and H&M Hennes & Mauritz (HM.B.SS)

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Technology +0.75%, Consumer Products and Services +0.40%, Energy+0.27%, Basic Resources +0.25%, Autos & Parts (0.12%), Chemicals (0.20%), Financial Svcs (0.27%)

      • Underperformers:

        • Construct & Mtls (1.00%), Utilities (0.91%), Food, Beverage and Tobacco (0.71%), Ind Goods & Svcs (0.66%), Banks (0.63%), Real Estate (0.59%), Travel & Leisure (0.56%), Retail (0.55%), Insurance (0.52%), Telecom (0.45%), Media (0.44%), Personal Care Drug and Grocery Stores (0.31%)

    • Macro:

      • EU:

        • EU trade commissioner to seek relief from export barriers during China visit - FT

        • Grim Euro-Area private sector suggests quarterly contraction - Bloomberg

        • Euro zone economy likely contracted this quarter - Reuters

      • Bulgaria:

        • Bulgarian nationalists protest against NATO bases, want government out - Reuters

      • France:

        • France's services sector contracts sharply in September - Reuters

      • Germany:

        • Shrinking German business activity points to third-quarter contraction - Reuters

        • German housing prices show sharpest drop since 2000 y/y - Reuters

      • Italy:

        • Italy sees 2023 budget deficit overshoot at around 5.5% of GDP, sources say - Reuters

        • Italy requests fourth NRRP installment from EU - ansa

        • EU allocates €127M to Tunisia under migrant memorandum - ansa

        • German government to fund migrant NGOs in Italy - ansa

      • UK:

        • Sterling dips after weaker-than-expected UK retail data - Reuters

        • British retail sales rebound as shoppers return to high streets - FT

        • Voters aren't talking about Brexit, says Lib Dem leader - BBC

        • Tax cuts are virtually impossible, says Jeremy Hunt - Telegraph

        • Labour plans more powers for economic watchdog - Times

        • Tories seize on Starmer comments over divergence from EU rules - FT

    • Company news:

      • Notable Gainers

        • +26.1% OPG.LN (OPG Power Ventures £0.10, +0.02) -- FY trading update: FY23 financial results expected in line with market expectations;

        • +15.4% RQIH.LN (R&Q Insurance Holdings £0.57, +0.08) -- confirms potential sale of Accredited

        • +12.9% SCHA.NO (Schibsted NOK247.70, +28.30) -- takeover proposal for Adevinta from consortium led by Permira and Blackstone

        • +10.8% MTC.LN (Mothercare £0.05, -0.00) -- FY earnings

        • +6.0% ASCL.LN (Ascential £2.02, +0.12) -- H1 earnings

        • +5.8% BIOG.B.SS (BioGaia SEK101.10, +5.50) -- Handelsbanken upgrade

        • +5.2% BINV.SS (BioInvent International SEK17.68, +0.88) -- first patient recruited in Phase 2a trial of single agent BI-1808 for the treatment of advanced malignancies

        • +4.5% UBI.FP (Ubisoft Entertainment €29.44, +1.26) -- CMA decision on new Microsoft/Activision deal

        • +4.0% BELA.GA (Jumbo €26.38, +1.02) -- H1 earnings

        • +3.2% RAT.LN (Rathbones Group £18.06, +0.56) -- resumed buy at Peel Hunt

        • +3.0% RENX.LN (Renalytix £0.85, +0.03) -- contract

        • +2.8% SRS.IM (Saras €1.43, +0.04) -- Mediobanca upgrade

        • +2.7% MDF.SM (Duro Felguera €0.65, +0.02) -- sale of 60% of Epicom S.A. for €5.3M

        • +2.0% ERA.FP (Eramet €71.65, +1.40) -- completes sale of its Norwegian subsidiary Eramet Titanium & Iron to Ineos Enterprises for $245M

        • +2.0% JUN3.GR (Jungheinrich €29.04, +0.56) -- initiated overweight at Barclays

        • +1.5% KER.FP (Kering €460.45, +6.85) -- shares higher; likely due to a Reuters report stating that new Gucci Director, Sabato de Sarno is showcasing his first collection

      • Notable Decliners

        • -16.8% S30.FP (Solutions 30 €2.20, -0.44) -- H1 earnings

        • -9.7% SERI.IM (Seri Industrial €3.68, -0.40) -- H1 earnings

        • -3.0% HOT.GR (Hochtief €95.55, -3.00) -- Societe Generale downgrade

        • -2.0% STERV.FH (Stora Enso €11.48, -0.23) -- BNP Paribas Exane downgrade

        • -2.0% AGY.LN (Allergy Therapeutics £0.03, -0.00) -- may require additional funding in Nov

        • -1.9% GMAA.LN (Gama Aviation £0.53, -0.01) -- H1 earnings

        • -1.9% ATE.FP (Alten €126.20, -2.50) -- H1 earnings

        • -1.8% ITV.LN (ITV £0.73, -0.01) -- acquires plant-based meat business THIS

        • -1.6% PHNX.LN (Phoenix Group Holdings £5.27, -0.09) --

          • Phoenix Group acquires 5% stake in holding company of Hambro Perks; terms undisclosed - FT

          • JPMorgan downgrade

    • EU companies reporting Monday:

      • Earnings:

        • France: Aelis Farma (AELIS.FP), Carmat (ALCAR.FP)

        • UK: Alphawave IP Group (AWE.LN), Wilmington (WIL.LN), IQGeo Group (IQG.LN), Real Estate Investors (RLE.LN)

      • CMD/events: TotalEnergies (TTE.FP) Energy Outlook, Pharming Group (PHARM.NA) EGM to elect chairman, Sage Group (SGE.LN) Innovation and Product webinar, CRH (CRH.LN) investor presentation to mark the transition of its primary listing to the NYSE

  • Data:

    • Economics:

      • Sep Flash Manufacturing PMI

        • France 43.6 vs consensus 46.0 and prior 46.0

        • Germany 39.8 vs consensus 39.5 and prior 39.1

        • Eurozone 43.4 vs consensus 44 and prior 43.5

        • UK 46.8 vs consensus 43.0 and prior 43.0

      • Sep Flash Services PMI

        • France 43.9 vs consensus 46.0 and prior 46.0

        • Germany 49.8 vs consensus 47.2 and prior 47.3

        • Eurozone 48.4 vs consensus 47.7 and prior 47.9

        • UK 47.2 vs consensus 49.2 and prior 49.5

      • UK Aug Retail Sales (1.4%) y/y vs consensus (1.2%) and prior revised (3.1%) from (3.2%); +0.4% m/m vs consensus +0.5% and prior revised (1.1%) from (1.2%)

      • Netherlands Q2 GDP (0.2%) y/y vs preliminary (0.3%); (0.2%) q/q vs preliminary (0.3%)

      • Spain Q2 GDP +2.2% y/y vs preliminary +1.8%; +0.5% q/q vs preliminary +0.4%

    • Markets:

      • WTI Crude (Nov 23): +$0.77 or +0.86% to $90.40

      • €-$ (0.0000) or (0.00%) to 1.0661

      • £-$ (0.0032) or (0.26%) to 1.2264

      • €-£ +0.0023 to 0.8694

      • S&P 500 +0.59%

      • Performance year-to-date

        • FTSE 100: +3.12%

        • DAX: +11.73%

        • CAC: +10.98%

        • MIB: +20.54%

        • Stoxx 600: +6.68%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE